Abstract
Upregulation of tRNA m7G methyltransferase complex components METTL1 and WDR4 promotes lenvatinib resistance in HCC and confers a sensitivity to METTL1 targeting, providing a promising strategy to override resistance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have